冠状动脉旁路移植术后心脏生物标志物的性别特异性阈值
该研究纳入2008至2021年2个三级大学中心连续3687例CABG患者(女性643例,17.4%;男性3044例,82.6%),分析术后系列cTn和CK-MB。女性术后cTn水平较低(69.18 vs 77.57倍URL,P<.001)。预测30天MACE的cTn最佳阈值女性为94.36倍URL、男性为206.07倍URL;被通用阈值遗漏的女性患者30天MACE或死亡风险升高。
要点
- 女性CABG术后cTn释放低于男性(69.18 vs 77.57倍URL,P<.001)。
- 预测30天MACE的cTn阈值:女性94.36倍URL,男性206.07倍URL。
- 被通用阈值遗漏的女性30天MACE和死亡风险升高。
核心结论
- CABG术后结局和生物标志物释放存在性别差异,诊断围术期心肌损伤需性别特异性cutoff以改善女性结局。
研究设计与样本
- 连续队列研究,纳入2008至2021年2个三级大学中心3687例CABG患者(女性643例,17.4%;男性3044例,82.6%),术后系列检测cTn和CK-MB。
主要发现
- 女性术后cTn水平低于男性(69.18 vs 77.57倍URL,P<.001)。
- 预测30天MACE的cTn最佳阈值:女性94.36倍URL,男性206.07倍URL。
- 被通用阈值遗漏的女性30天MACE风险升高(cTn:OR 3.78,95%CI 1.03-13.08,P=.035;CK-MB:OR 10.04,95%CI 2.07-48.75,P<.001)。
- 被通用阈值遗漏的女性30天死亡风险升高(cTn:OR 4.98,95%CI 1.20-20.61,P=.027;CK-MB:OR 13.59,95%CI 2.66-69.47,P=.002)。
关键数值与推荐
- 预测30天MACE的cTn阈值:女性94.36倍URL,男性206.07倍URL。
- 女性被通用阈值遗漏时30天MACE的OR:cTn 3.78(95%CI 1.03-13.08,P=.035),CK-MB 10.04(95%CI 2.07-48.75,P<.001)。
- 女性被通用阈值遗漏时30天死亡的OR:cTn 4.98(95%CI 1.20-20.61,P=.027),CK-MB 13.59(95%CI 2.66-69.47,P=.002)。
临床怎么用
- CABG术后诊断围术期心肌损伤时,可考虑采用性别特异性cTn和CK-MB阈值以识别高风险女性患者。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The impact of sex-differences on the release of cardiac biomarkers after coronary artery bypass grafting (CABG) remains unknown. The aim of our study was to (1) investigate the impact of sex-differences in cardiac biomarker release after CABG and (2) determine sex-specific thresholds for high-sensitivity cardiac troponin (hs-cTn) and creatine kinase-myocardial band (CK-MB) associated with 30-day major adverse cardiovascular events (MACE) and mortality. METHODS: A consecutive cohort of 3687 patients, comprising 643 women (17.4%) and 3044 men (82.6%), undergoing CABG from 2008 to 2021 in 2 tertiary university centers with serial postoperative cTn and CK-MB measurement was analyzed. The composite primary outcome was MACE at 30 days. Secondary end points were 30-day mortality and 5-year mortality and MACE. Sex-specific thresholds for cTn and CK-MB were determined. RESULTS: Lower levels of cTn were found in women after CABG (69.18 vs 77.57 times the upper reference limit [URL]; P < .001). The optimal threshold value for cTn was calculated at 94.36 times the URL for female patients and 206.07 times the URL for male patients to predict 30-day MACE. Female patients missed by a general threshold had increased risk for MACE or death within 30 days (cTn: MACE: odds ratio [OR], 3.78; 95% CI, 1.03-13.08; P = .035; death: OR, 4.98; 95% CI, 1.20-20.61; P = .027; CK-MB: MACE: OR, 10.04; 95% CI, 2.07-48.75; P < .001; death: OR 13.59; 95% CI, 2.66-69.47; P = .002). CONCLUSIONS: We provide evidence for sex-specific differences in the outcome and biomarker release after CABG. Sex-specific cutoffs are necessary for the diagnosis of perioperative myocardial injury to improve outcomes of women after CABG.
引用
- Pölzl L, Thielmann M, Sterzinger P, et al. Sex-Specific Troponin and Creatine Kinase Thresholds After Coronary Bypass Surgery. Ann Thorac Surg. 2024. PMID: 38964702. doi:10.1016/j.athoracsur.2024.06.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。